Second Tokushima Factory Otsuka Pharmaceutical recalls

Second Tokushima Factory Otsuka Pharmaceutical appears in 4 official U.S. recall notices indexed by RecallRadar, most recently on 2024-05-01.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95),…
  FDA Drug · Class III · 2024-05-01 · Second Tokushima Factory Otsuka Pharmaceutical
• Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13
  FDA Drug · Class III · 2024-05-01 · Second Tokushima Factory Otsuka Pharmaceutical
• Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
  FDA Drug · Class III · 2024-05-01 · Second Tokushima Factory Otsuka Pharmaceutical
• Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
  FDA Drug · Class III · 2024-05-01 · Second Tokushima Factory Otsuka Pharmaceutical